In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

When Illumina Buys Roche: The Dawning Of The Era Of Diagnostics Dominance

Executive Summary

With current technology and resources, a well-funded in vitro diagnostics company can create and pursue a strategy of information gathering and informatics application to create medical knowledge, enabling it to assume the risk and manage certain segments of patients. But few if any pharma or diagnostics firms appear poised to take advantage.

Advertisement

Related Content

Diagnostics In 2016: From Alere To Zika
Digital Health Is Changing Health Care. Is it Changing Pharma?
Matchmaking And Integration In The New World Of Diagnostics M&A
Solution Development: A Model For Structuring Biotechs And Developing Better Drugs
Genomics Through The Lens Of Precompetitive Data Sharing
The Long Goodbye: Lilly Finally Kicks Troubled Sepsis Drug Xigris To The Curb
Is Diagnostics the New Biotech...and Will Pharma Embrace It?
Novartis Follows Its Own Business Development Model into Molecular Diagnostics
Roche Finally Gets Nod With Sweetened $3.4 Billion Bid For Ventana
Does Roche Have It Right?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004243

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel